PT005 MDI Dose Ranging Versus Foradil Aerolizer Study

NCT01349868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: PT005 MDI
DRUG: Formoterol Fumarate 12 μg (Foradil® Aerolizer®)
DRUG: Formoterol Fumarate 24 μg (Foradil® Aerolizer®)
OTHER: Placebo MDI

Sponsor

Pearl Therapeutics, Inc.